Reducing SELEX cycles
Increasing success rate
Amenable to chemical conjugation post synthesis (i.e. toxin, half life extension compounds)
© 2023 Guardian Therapeutics. All rights reserved.
Welcome to the Guardian Therapeutics and Band Therapeutics website. We do not use any cookies or other technologies on this website, except those that are strictly necessary to enable normal functioning of this web page. View our data protection statement.
101 Hartwell Avenue
Lexington, MA 02421
+1 (781) 918-6580
Business Development Inquiries: firstname.lastname@example.org